Which has grown faster, MYGN or SRTA?

Over the past five years, SRTA grew revenue faster — MYGN at a 9.70% CAGR versus SRTA at 46.05%.

Is MYGN or SRTA more profitable?

SRTA runs the higher net margin — MYGN at -13.96% versus SRTA at 15.71%.

How have MYGN and SRTA total returns compared?

Over the past 5 years, MYGN delivered -32.02% and SRTA delivered -13.77% annualized total return. Past performance doesn't predict future results.

Myriad Genetics, Inc. (MYGN) vs Strata Critical Medical, Inc. (SRTA)

A side-by-side comparison of Myriad Genetics, Inc. and Strata Critical Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MYGN

Myriad Genetics, Inc.

$404M

$4.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SRTA

Strata Critical Medical, Inc.

$411M

$4.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — MYGN vs SRTA

growth of $100 · dividends reinvested · last 7y

MYGN -87.0% (-25.2%/yr)SRTA -50.7% (-9.6%/yr)SRTA compounded faster over this window

MYGN SRTA

MYGN vs SRTA: by the numbers

•SRTA is the larger company ($411M vs $404M market cap).
•SRTA is profitable (15.71% net margin) while MYGN runs a net loss (-13.96%).
•SRTA grew revenue faster over the past five years (46.05% vs 9.70% CAGR).

Metrics side by side

Valuation

Metric	MYGN	SRTA
P/E ratio	N/A	9.54
P/S ratio	0.50	1.61
P/B ratio	1.33	1.47

Profitability

Metric	MYGN	SRTA
Gross margin	68.83%	20.56%
Operating margin	-12.22%	-7.97%
Net margin	-13.96%	15.71%
ROE	-37.05%	14.40%
ROIC	-19.13%	-7.11%

Growth (annualized)

Metric	MYGN	SRTA
Revenue CAGR (5Y)	9.70%	46.05%
Total return CAGR (5Y)	-32.02%	-13.77%

Frequently asked

Which has grown faster, MYGN or SRTA?: Over the past five years, SRTA grew revenue faster — MYGN at a 9.70% CAGR versus SRTA at 46.05%.
Is MYGN or SRTA more profitable?: SRTA runs the higher net margin — MYGN at -13.96% versus SRTA at 15.71%.
How have MYGN and SRTA total returns compared?: Over the past 5 years, MYGN delivered -32.02% and SRTA delivered -13.77% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MYGN analysis Full SRTA analysis Interactive comparison tool

Dig into the metrics

Strata Critical Medical P/E ratio Myriad Genetics ROE Strata Critical Medical ROE Myriad Genetics operating margin Strata Critical Medical operating margin Myriad Genetics revenue growth Strata Critical Medical revenue growth Myriad Genetics free cash flow Strata Critical Medical free cash flow

Myriad Genetics & Strata Critical Medical appear in these rankings

Fastest Revenue Growth Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.